Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.

Koens L, Vermeer MH, Willemze R, Jansen PM.

Am J Surg Pathol. 2010 Jul;34(7):1043-8. doi: 10.1097/PAS.0b013e3181e5060a.

PMID:
20551823
2.

The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.

Demirkesen C, Tüzüner N, Esen T, Lebe B, Ozkal S.

Leuk Res. 2011 Sep;35(9):1269-72. doi: 10.1016/j.leukres.2011.06.004. Epub 2011 Jun 22.

PMID:
21700336
3.

Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.

Belaud-Rotureau MA, Marietta V, Vergier B, Mainhaguiet G, Turmo M, Idrissi Y, Ferrer J, Beylot-Barry M, Dubus P, Merlio JP.

Virchows Arch. 2008 Jun;452(6):607-20. doi: 10.1007/s00428-008-0593-x. Epub 2008 Mar 1.

PMID:
18311490
4.

Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.

Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R; Dutch Cutaneous Lymphoma Group.

Arch Dermatol. 2007 Dec;143(12):1520-6.

PMID:
18087001
5.

Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.

Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, Canninga-van Dijk MR, Geerts ML, Hebeda KM, Kluin PM, Lam KH, Meijer CJ, Willemze R.

J Clin Oncol. 2007 Apr 20;25(12):1581-7. Epub 2007 Mar 12.

PMID:
17353548
6.

Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.

Mao X, Orchard G.

Br J Dermatol. 2008 Jul;159(1):145-51. doi: 10.1111/j.1365-2133.2008.08579.x. Epub 2008 Jul 1.

PMID:
18460027
7.

Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.

van Galen JC, Hoefnagel JJ, Vermeer MH, Willemze R, Dijkman R, Tensen CP, de Boer WP, Meijer CJ, Oudejans JJ.

J Pathol. 2008 Jul;215(3):340-6. doi: 10.1002/path.2374.

PMID:
18498125
8.

Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.

Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T.

Arch Dermatol. 2007 Sep;143(9):1144-50.

PMID:
17875875
9.
10.

Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.

Felcht M, Heck M, Weiss C, Becker JC, Dippel E, Müller CS, Nashan D, Sachse MM, Nicolay JP, Booken N, Goerdt S, Klemke CD.

Br J Dermatol. 2012 Aug;167(2):348-58. doi: 10.1111/j.1365-2133.2012.10987.x. Epub 2012 Jul 5.

PMID:
22512270
11.

Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.

Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R, Tensen CP, Vermeer MH.

Blood. 2005 May 1;105(9):3671-8. Epub 2004 Aug 12.

12.

The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.

Felcht M, Booken N, Stroebel P, Goerdt S, Klemke CD.

J Am Acad Dermatol. 2011 Jan;64(1):135-43, 143.e1-4. doi: 10.1016/j.jaad.2009.12.062.

PMID:
21167409
13.

Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization.

Yang B, Tubbs RR, Finn W, Carlson A, Pettay J, Hsi ED.

Am J Surg Pathol. 2000 May;24(5):694-702.

PMID:
10800988
14.

Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.

Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL.

J Am Acad Dermatol. 2013 Sep;69(3):329.e1-13; quiz 341-2. doi: 10.1016/j.jaad.2013.06.012. Review.

PMID:
23957984
15.

Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.

Hristov AC.

Arch Pathol Lab Med. 2012 Aug;136(8):876-81. doi: 10.5858/arpa.2012-0195-RA. Review.

PMID:
22849734
17.

Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.

Dijkman R, Tensen CP, Jordanova ES, Knijnenburg J, Hoefnagel JJ, Mulder AA, Rosenberg C, Raap AK, Willemze R, Szuhai K, Vermeer MH.

J Clin Oncol. 2006 Jan 10;24(2):296-305. Epub 2005 Dec 5.

PMID:
16330669
18.

Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.

Hoefnagel JJ, Vermeer MH, Jansen PM, Fleuren GJ, Meijer CJ, Willemze R.

Br J Dermatol. 2003 Dec;149(6):1183-91.

PMID:
14674895
19.

Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.

Paulli M, Viglio A, Vivenza D, Capello D, Rossi D, Riboni R, Lucioni M, Incardona P, Boveri E, Bellosta M, Orlandi E, Borroni G, Lazzarino M, Berti E, Alessi E, Magrini U, Gaidano G.

Hum Pathol. 2002 Sep;33(9):937-43.

PMID:
12378521
20.

Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.

Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P.

Exp Dermatol. 2011 Apr;20(4):331-5. doi: 10.1111/j.1600-0625.2010.01226.x.

PMID:
21410763

Supplemental Content

Support Center